檢索結果 - Keith Stockerl‐Goldstein

Refine Results
  1. 1
    Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis

    Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis 由 Kathleen W. Zhang, Keith Stockerl‐Goldstein, Daniel J. Lenihan

    出版 2019
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome

    A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome 由 Peggy A. Wu, Youn H. Kim, Phillip W. Lavori, Richard T. Hoppe, Keith Stockerl‐Goldstein

    出版 2009
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Socioeconomic status is independently associated with overall survival in patients with multiple myeloma

    Socioeconomic status is independently associated with overall survival in patients with multiple myeloma 由 Mark A. Fiala, Joseph D Finney, Jingxia Liu, Keith Stockerl‐Goldstein, Michael H. Tomasson, Ravi Vij, Tanya M. Wildes

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Geriatric Assessment in Older Adults with Multiple Myeloma

    Geriatric Assessment in Older Adults with Multiple Myeloma 由 Tanya M. Wildes, Sascha A. Tuchman, Heidi D. Klepin, Joseph Mıkhael, Kathryn Trinkaus, Keith Stockerl‐Goldstein, Ravi Vij, Graham A. Colditz

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients

    Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients 由 Susanne Auffermann-Gretzinger, Izidore S. Lossos, Tamara Vayntrub, Wendy Leong, F. Carl Grumet, Karl G. Blume, Keith Stockerl‐Goldstein, Ronald Levy, Judith A. Shizuru

    出版 2002
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma

    Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma 由 Arcangelo Liso, Keith Stockerl‐Goldstein, Susanne Auffermann-Gretzinger, Claudia Benike, Volker L. Reichardt, Adrienne van Beckhoven, Ranjani Rajapaksa, Edgar G. Engleman, Karl G. Blume, Ronald Levy

    出版 2000
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Fresh or Cryopreserved CD34 + -Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function after Allogeneic Hematopoietic Cell Transplantation

    Fresh or Cryopreserved CD34 + -Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function after Allogeneic Hematopoietic Cell Transplant... 由 Armin Ghobadi, Mark A. Fiala, Giridharan Ramsingh, Feng Gao, Camille N. Abboud, Keith Stockerl‐Goldstein, Geoffrey L. Uy, Brenda J. Grossman, Peter Westervelt, John F. DiPersio

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor

    Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor 由 Gian Paolo Fadini, Mark A. Fiala, Roberta Cappellari, Marianna D’Anna, Soohyung Park, Nicol Poncina, Lisa Menegazzo, Mattia Albiero, John F. DiPersio, Keith Stockerl‐Goldstein, Angelo Avogaro

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

    Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma 由 Sarah McCue Horwitz, Robert S. Negrin, Karl G. Blume, Sheila Breslin, Monic J. Stuart, Keith Stockerl‐Goldstein, Laura Johnston, Ruby M. Wong, Judith A. Shizuru, Sandra J. Horning

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia

    A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia 由 Todd A. Fehniger, Geoffrey L. Uy, Kathryn Trinkaus, Alissa Nelson, Jeffery A Demland, Camille N. Abboud, Amanda F. Cashen, Keith Stockerl‐Goldstein, Peter Westervelt, John F. DiPersio, Ravi Vij

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related Mortality

    Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related Mortality 由 Lawrence Liu, Alicia Yn, Feng Gao, Marissa Olson, Mallory Crain, Ramzi Abboud, Peter Westervelt, Camille N. Abboud, Ravi Vij, Keith Stockerl‐Goldstein, Iskra Pusic, Amanda F. Cashen, Mark A. Schroeder

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome

    Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome 由 Iskra Pusic, Jaebok Choi, Mark A. Fiala, Feng Gao, Matthew Holt, Amanda F. Cashen, Ravi Vij, Camille N. Abboud, Keith Stockerl‐Goldstein, Meghan A. Jacoby, Geoffrey L. Uy, Peter Westervelt, John F. DiPersio

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation

    Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation 由 Iskra Pusic, Shi Yuan Jiang, Scott Landua, Geoffrey L. Uy, Michael P. Rettig, Amanda F. Cashen, Peter Westervelt, Ravi Vij, Camille N. Abboud, Keith Stockerl‐Goldstein, Diane S. Sempek, Angela Smith, John F. DiPersio

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

    A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia 由 Geoffrey L. Uy, Michael P. Rettig, Ibraheem Motabi, Kyle McFarland, Kathryn Trinkaus, Lindsay Hladnik, Shashikant Kulkarni, Camille N. Abboud, Amanda F. Cashen, Keith Stockerl‐Goldstein, Ravi Vij, Peter Westervelt, John F. DiPersio

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Risk of Marrow Neoplasms After Adjuvant Breast Cancer Therapy: The National Comprehensive Cancer Network Experience

    Risk of Marrow Neoplasms After Adjuvant Breast Cancer Therapy: The National Comprehensive Cancer Network Experience 由 Antonio C. Wolff, Amanda L. Blackford, Kala Visvanathan, Hope S. Rugo, Beverly Moy, Lori J. Goldstein, Keith Stockerl‐Goldstein, Leigh Neumayer, Terry S. Langbaum, Richard L. Theriault, Melissa E. Hughes, Jane C. Weeks, Judith E. Karp

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Protective Conditioning for Acute Graft-versus-Host Disease

    Protective Conditioning for Acute Graft-versus-Host Disease 由 Robert Lowsky, Tsuyoshi Takahashi, Yin Ping Liu, Sussan Dejbakhsh‐Jones, F. Carl Grumet, Judith A. Shizuru, Ginna G. Laport, Keith Stockerl‐Goldstein, Laura Johnston, Richard T. Hoppe, D. Blöch, Karl G. Blume, Robert S. Negrin, Samuel Strober

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Prognostic Significance of FDG-PET in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Standard Salvage Chemotherapy and Autologous Stem Cell Transplantation

    Prognostic Significance of FDG-PET in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Standard Salvage Chemotherapy and Autologous Stem Cell Transplantation 由 Jacob P. Smeltzer, Amanda F. Cashen, Qin Zhang, Andrew Homb, Farrokh Dehdashti, Camille N. Abboud, John F. DiPersio, Keith Stockerl‐Goldstein, Geoffrey L. Uy, Ravi Vij, Peter Westervelt, Nancy L. Bartlett, Todd A. Fehniger

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission

    Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission 由 Daniel J. Weisdorf, Heather R. Millard, Mary M. Horowitz, Parvinder Hyare, Richard E. Champlin, Vincent T. Ho, Marco Mielcarek, Andrew R. Rezvani, Keith Stockerl‐Goldstein, H. Jean Khoury, Marcos de Lima, Wael Saber, Brenda M. Sandmaier, Mei Jie Zhang, Mary Eapen

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia

    A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia 由 Geoffrey L. Uy, Michael P. Rettig, Richard M. Stone, Marina Konopleva, Michael Andreeff, Kyle McFarland, William D. Shannon, Theresa Fletcher, Teresa Reineck, William Eades, Keith Stockerl‐Goldstein, Camille N. Abboud, Meagan A. Jacoby, Peter Westervelt, John F. DiPersio

    出版 2017
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  20. 20
    Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure

    Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure 由 David S. Siegel, Gary J. Schiller, Kevin Song, Richy Agajanian, Keith Stockerl‐Goldstein, Hakan Kaya, Michaël Sébag, Christy Samaras, Ehsan Malek, Giampaolo Talamo, Christopher S. Seet, Jorge Mouro, William E. Pierceall, Faiza Zafar, Weiyuan Chung, Shankar Srinivasan, Amit Agarwal, Nizar J. Bahlis

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: